0.16
-3.03%
Close of 9 Nov 2026, in AUD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Optiscan Imaging
Its shares trade on ASX under the ticker OIL.AX. It has been listed since 8 August 1997. In the fiscal year to 30 June 2025, it reported revenue of A$3.7m and a net loss of A$6.3m. At that date it held total assets of A$10.6m and shareholders' equity of A$7.7m.
Optiscan Imaging Ltd. is engaged in the development of endomicroscopic imaging technologies for medical, translational and pre-clinical applications. The company is headquartered in Mulgrave, Victoria. The firm has two business segments: realisation (trading), and research and development. The realization (trading) segment comprises manufacturing and sales of confocal imaging products. The research and development segment's activities include design and development of new products and technologies, including related income from customers. The firm's products are Pentax ISC-1000 and Optiscan FIVE1. Pentax ISC-1000 product has adopted its technology in the management of Barrett's Oesophagus and the prevention of oesophageal adenocarcinoma (Barrett's cancer). The Optiscan FIVE1 is a fluorescence endomicroscope that has been designed for in vivo investigations of animal tissues. The FIVE1 enables a range of animal imaging studies in different organ systems.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 8 Aug 1997
- Employees
- 8
- Website
- optiscan.com ↗
Leadership
Pay as last reported
- Mr. Robert CookeNon-Executive Chairman of the BoardA$252,009
- Prof. Camile FarahChief Executive Officer, Managing Director, Executive Director, since 2021A$408,966
- Mr. Brendan FafianiChief Operating Officer
- Ms. Elissa HansenCompany Secretary
- Ms. Karen BorgNon-Executive DirectorA$148,657
- Mr. Sean GardinerNon-Executive Director
- Mr. Ron SongNon-Executive DirectorA$47,666
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Cutting-edge imaging technology: Optiscan Imaging Ltd possesses advanced imaging technology, allowing them to provide high-resolution and accurate imaging solutions.
- Strong patent portfolio: The company holds a significant number of patents, providing them with a competitive advantage and protecting their innovative products.
- Established brand reputation: Optiscan Imaging Ltd has built a solid reputation for delivering reliable and high-quality imaging products, earning trust from customers and industry experts.
Weaknesses
- Limited market presence: Despite their strengths, Optiscan Imaging Ltd faces challenges in terms of market reach, particularly in expanding their customer base beyond their current target segments.
- Dependency on key suppliers: The company relies heavily on a few suppliers for critical components, which exposes them to potential disruptions in the supply chain.
- Relatively small R&D budget: Optiscan Imaging Ltd's R&D budget is comparatively smaller than some competitors, limiting their ability to invest in new product development and innovation.
Opportunities
- Increasing demand for medical imaging: The healthcare industry's growing need for advanced imaging solutions presents an opportunity for Optiscan Imaging Ltd to expand its market share and revenue.
- Emerging markets: Optiscan Imaging Ltd can explore untapped markets in developing regions, where the adoption of advanced medical technology is on the rise.
- Partnerships and collaborations: Collaborating with research institutions, medical centers, and industry partners can enhance Optiscan Imaging Ltd's research capabilities and open doors to new technological advancements.
Threats
- Intense competition: Optiscan Imaging Ltd operates in a highly competitive market with both established players and new entrants, increasing the pressure to differentiate and innovate.
- Evolving regulations: Changing regulations and compliance requirements in the healthcare industry can pose challenges and increase the complexity of product development and market entry.
- Technological advancements: Rapid advancements in imaging technology may require substantial investments to keep up with the pace of innovation, potentially straining Optiscan Imaging Ltd's resources.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.